Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
GLP-1 Drugs, Vitamin D and Resistance Training Reshape Diabetes and Obesity CareLongevity & Aging

GLP-1 Drugs, Vitamin D and Resistance Training Reshape Diabetes and Obesity Care

This news roundup covers several important developments in metabolic and endocrine health. GLP-1 receptor agonists after bariatric surgery amplified weight loss in a dose- and timing-dependent way. A microsimulation study found vitamin D supplementation in adults with prediabetes could cut lifetime diabetes incidence by 8%, saving over $15,000 per person. Long-term resistance training was linked to significantly lower type 2 diabetes risk in over 140,000 healthcare professionals. New investigational drugs — including oral GLP-1 agent CX11 and bofanglutide — showed promising results in early trials. HHS also proposed relaxing testosterone labeling warnings, and women with a history of premature adrenarche were found to face elevated insulin resistance risk long-term.

0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.